High-dose myeloablative radioimmunotherapy of mantle cell non-Hodgkin lymphoma with the iodine-131-labeled chimeric anti-CD20 antibody C2B8 and autologous stem cell support. Results of a pilot study.
Behr, Thomas M
High-dose myeloablative radioimmunotherapy of mantle cell non-Hodgkin lymphoma with the iodine-131-labeled chimeric anti-CD20 antibody C2B8 and autologous stem cell support. Results of a pilot study. [electronic resource] - Cancer Feb 2002 - 1363-72 p. digital
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Retracted Publication
0008-543X
10.1002/cncr.10307 doi
Adult
Antibodies--chemistry
Antigens, CD20--immunology
Antineoplastic Agents--administration & dosage
Female
Hematopoietic Stem Cell Transplantation
Humans
Immunoconjugates--administration & dosage
Iodine Radioisotopes--administration & dosage
Lymphoma, Mantle-Cell--drug therapy
Lymphoma, Non-Hodgkin--drug therapy
Male
Middle Aged
Pilot Projects
Radioimmunotherapy
Radiometry
Treatment Outcome
High-dose myeloablative radioimmunotherapy of mantle cell non-Hodgkin lymphoma with the iodine-131-labeled chimeric anti-CD20 antibody C2B8 and autologous stem cell support. Results of a pilot study. [electronic resource] - Cancer Feb 2002 - 1363-72 p. digital
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Retracted Publication
0008-543X
10.1002/cncr.10307 doi
Adult
Antibodies--chemistry
Antigens, CD20--immunology
Antineoplastic Agents--administration & dosage
Female
Hematopoietic Stem Cell Transplantation
Humans
Immunoconjugates--administration & dosage
Iodine Radioisotopes--administration & dosage
Lymphoma, Mantle-Cell--drug therapy
Lymphoma, Non-Hodgkin--drug therapy
Male
Middle Aged
Pilot Projects
Radioimmunotherapy
Radiometry
Treatment Outcome